merck-p53-stapled-peptide-patent Mesothelin-related peptide (SMRP) has emerged as a critical biomarker in the field of oncology, particularly in the diagnosis and management of malignant pleural mesothelioma (MPM). This soluble mesothelin-related peptide represents a breakdown product of the mesothelin protein, which is found on the surface of normal mesothelial cells lining the body's cavities, including those surrounding the lungs, heart, and abdomen. However, in certain cancers, including mesothelioma, mesothelin is significantly overexpressed. SMRP is the form of mesothelin that is released by tumor cells into the bloodstream, making it detectable and measurable in biological fluids.
The search intent surrounding mesothelin-related peptide predominantly focuses on its role as a diagnostic tool for malignant pleural mesothelioma (MPM). Numerous studies have investigated the utility of serum concentrations of soluble mesothelin-related peptides (SMRP), consistently finding elevated levels in patients diagnosed with mesothelioma compared to healthy individuals. This elevation makes SMRP (soluble mesothelin-related peptides) a potential marker for malignant pleural mesothelioma, useful even for initial screening of high-risk populations, such as those exposed to asbestos.
The MESOMARK assay, an enzyme-linked immunosorbent assay (ELISA), is specifically designed for the quantitative measurement of soluble mesothelin-related peptides (SMRP).The ELISA Kit is designed to detect native, not recombinant, SMRP. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, ... This assay has been instrumental in advancing the diagnostic capabilities for mesotheliomaHuman Soluble Mesothelin Related Peptide (SMRP) Elisa Kit. Research indicates that SMRP in both serum and pleural fluid can be helpful markers for diagnosing MPM with a similar diagnostic accuracy.Soluble Mesothelin-Related Peptides Furthermore, SMRP is recognized as a crucial biomarker for the diagnosis and monitoring of pleural malignant mesothelioma (MPM), with some sources noting it as the only FDA-approved biomarker for the diagnosis of pleural mesothelioma, thus underscoring its clinical importanceBiomatik Corporation Human SMRP (Soluble Mesothelin ....
The diagnostic value of soluble mesothelin-related peptides extends beyond initial detection. Research by Schneider et al.Human SMRP (Soluble Mesothelin Related Peptide) ... (2008) investigated the diagnostic and prognostic value of soluble mesothelin-related proteins (SMRP) in sera from patients with newly diagnosed malignant mesotheliomaDiagnostic value of soluble mesothelin-related peptides for .... Studies have also explored SMRP as a prognosticator. For instance, Mitra et alHigh stability of a potential tumor marker for mesothelioma. (2025) highlight that SMRP is a promising serum biomarker for predicting prognosis in patients with MPM undergoing treatment作者:A Cui·2014·被引用次数:104—SMRPs in both serum and pleural fluid are helpful markers for diagnosing MPM withsimilardiagnostic accuracy.. This dual role as both a diagnostic and prognostic indicator makes SMRP an invaluable tool in the clinical management of mesothelioma.Soluble Mesothelin-Related Peptides (MESOMARK)
While SMRP's primary association is with mesothelioma, the underlying protein, mesothelin, is expressed by normal mesothelial cells.Human Soluble Mesothelin Related Peptide ELISA Kit ... This fundamental characteristic contrasts sharply with its overexpression in specific cancers. The related nature of SMRP to the mesothelin/megakaryocyte potentiating factor (MPF) family of proteins is also a key factor in understanding its biological roleSoluble mesothelin-related peptide as a prognosticator in ....
Research is also exploring the association of other factors with SMRP levels2019年8月7日—Thesepeptidesare breakdown products from proteins found in the membranes lining the cavities that surround the lungs, heart, and abdomen.. For example, Santarelli et al.Human Soluble Mesothelin Related Peptide, SMRP ELISA ... (2011) proposed a potential role for miR-126, in association with SMRPs, as a marker for early detection of MPM. This research into tumor biomarkers used alone or in combination signifies the ongoing efforts to refine diagnostic strategies.
The availability of Human SMRP (Soluble Mesothelin Related Peptide) ELISA Kit and similar assays is crucial for the widespread application of SMRP as a biomarker. These kits are designed to detect native SMRP and are suitable for serum, plasma, tissue homogenates, and other biological fluids. The quantitative nature of these assays allows for precise measurement of SMRP concentrations, facilitating both clinical diagnosis and researchThis ELISA kit uses quantitative-ELISA as the method. The Micro-elisa strip plate provided in this kit has been pre-coated with an antibody specific to Soluble .... The Human Soluble Mesothelin Related Peptide ELISA Kit employs methods like the double antibody-sandwich ELISA, offering reliable and reproducible quantitation of mesothelin related peptides. The sensitivity of these kits, often reported in picomoles per milliliter (pmol/mL), ensures accurate detection.
In summary, soluble mesothelin-related peptide (SMRP) stands as a significant and validated biomarker. Its ability to aid in the diagnosis of mesothelioma when used in conjunction with other diagnostic methods, coupled with its prognostic value, makes it an indispensable tool in the fight against this devastating disease. Ongoing research continues to expand our understanding of SMRP and its potential applications in cancer diagnosticsThe ELISA Kit is designed to detect native, not recombinant, SMRP. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, ....
Join the newsletter to receive news, updates, new products and freebies in your inbox.